Oncology Partnering & Deal-Making Conference (OPDM)
|Event Date/Time: Feb 27, 2012||End Date/Time: Feb 28, 2012|
We have assembled an impressive group of speakers to address a broad range of topics, formally structured into the following sessions:
Sessions & Panels:
Investments, Partnerships & Acquisitions: Trends & Recent Deals
Regulatory and Reimbursement Trends & Updates
Innovative Partnering & Licensing Strategies
Trends in Oncology Drug Development
Novel Advances and Technologies in Oncology
This conference is also part of the Cancer Drug Discovery Summit which consists of three other conferences:
1) 4th Ocular Diseases Drug Discovery
2) 3rd Cancer Targets & Therapeutics
3) 2nd Ubiquitin in Drug Discovery
The top companies and experts in the Oncology field will come together to discuss the latest discoveries, technologies and partnership opportunities from their organization. Companies include A&G Pharmaceutical, Amgen, Astellas Pharma, Eisai , Eli Lilly, Endocyte, Epizyme, Knobbe Martens Olson & Bear, MedImmune, Micromet, Novartis, Pfizer , Plexxikon , Pullan Consulting, QIAGEN, Seattle Genetics, YM Biosciences, and many more!
We hope you can join your business development colleagues at this unique partnering forum.